Frier Levitt is returning to the Asembia Specialty Pharmacy Summit on
April 29th - May 2nd in Las Vegas. We hope to see you there!
Visit us at Booth # 719 or contact us today to schedule a meeting with a member of our team.
2019 has already presented significant challenges in the Specialty Pharmacy space. Frier Levitt works with specialty pharmacies and pharmaceutical manufacturers on a daily basis and is at the forefront of identifying and challenging the top issues impacting specialty pharmacy industry stakeholders, including:
- Pharma-pharmacy contracting and general relationships
- Payor and PBM contracting and negotiation
- Mergers & Acquisitions and pharmacy transactions
- Challenging DIR Fees and Generic Effective Rates (GER)
- PBM network exclusion and network admission
- Pharmacy and pharmacist licensing, as well as Board of Pharmacy actions
- Below market PBM reimbursements and specifically, challenging Medicaid NADAC or AAC Reimbursement
- Patient Assistance Programs
- Access and Reimbursement Strategies
- HUB relationships
- 3PL relationships
- Mailing limitations
- Medicaid licensure and 21st Century Cures Act implications
- 340B compliance for both Covered Entities and Contract Pharmacies
- Government investigations
- Self-Disclosure Protocol submissions
- And more!
If you or your company is having problems with these or other issues, or is simply interested in learning more about the complex issues in this dynamic space, Frier Levitt will have attorneys available at Asembia with whom you can speak.
If you are not attending this year's Asembia Summit and would like to discuss issues you or your pharmacy are experiencing,
contact us today to speak with an attorney.
We look forward to meeting with you!
Jonathan E. Levitt
Co-Founding Partner
Frier Levitt
|
